Pharmacotherapy for acute migraines in children and adolescents

References

• Charles A. Migraine. N Engl J Med. 2017;377(6):553–561.
   PubMed Web of Science ®Google Scholar
• Abu-Arefeh I, Russell G. Prevalence of headache and migraine in school children. BMJ. 1994;309:765–769.
   PubMed Web of Science ®Google Scholar
• Özge A, Faedda N, Abu-Arafeh I, et al. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain. 2017 23;18(1):109.
   PubMedGoogle Scholar
• Landy S. Migraine throughout the life cycle: treatment through the ages. Neurology. 2004;Suppl 2:S2–8.
   Google Scholar
• Cameron C, Kelly S, Hsieh SC, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache. 2015;Suppl 4:221–235.
   Google Scholar
• Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev. 2016 Apr;19(4):CD005220.
   Google Scholar
• Hämäläinen M. Oral sumatriptan for the acute treatment of migraine in children and adolescents: yet another failed study. Cephalalgia. 2014;34(5):325–326.
   PubMed Web of Science ®Google Scholar
• Kacperski J, Hershey AD. Newly approved agents for the treatment and prevention of pediatric migraine. CNS Drugs. 2016;30(9):837–844.
   PubMed Web of Science ®Google Scholar
• Hamalainen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults? Neurology. 1997;48:1100–1103.
   PubMed Web of Science ®Google Scholar
• Fujita M, Sato K, Nishioka H, et al. Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia. 2014;34(5):365–375.
   PubMed Web of Science ®Google Scholar
• Ueberall MA, Wenzel D. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507–1510.
   PubMed Web of Science ®Google Scholar
• Ahonen K, Hamalainen ML, Rantala H, et al. Nasal sumatriptan is effective in treatment of migraine attacks in children: a randomized trial. Neurology. 2004;62:883–887.
   PubMed Web of Science ®Google Scholar
• Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989–997.
   PubMed Web of Science ®Google Scholar
• Winner P, Rothner AD, Wooten JD, et al. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo controlled, acute study. Headache. 2006;46:212–222.
   PubMed Web of Science ®Google Scholar
• Rothner AD, Winner P, Nett R, et al. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study. Clin Ther. 2000;22:1533–1546.
   PubMed Web of Science ®Google Scholar
• Natarajan S, Jabbour JT, Webster CJ, et al. Long term tolerability of sumatriptan nasal spray in adolescent patients with migraine. Headache. 2004;44:969–977.
   PubMed Web of Science ®Google Scholar
• Pakalnis A, Kring D, Paolicchi J. Parental satisfaction with sumatriptan nasal spray in childhood migraine. J Child Neurol. 2003;18:772–775.
   PubMed Web of Science ®Google Scholar
• MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581–582.
   PubMed Web of Science ®Google Scholar
• Linder SL. Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practise. Headache. 1996;36:419–422.
   PubMed Web of Science ®Google Scholar
• Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012;129(6):1411–1420.
   PubMed Web of Science ®Google Scholar
• McDonald SA, Hershey AD, Pearlman E, et al. Long-term evaluation sumatriptan and naproxen sodium for the acute treatment of migraine in adolescent. Headache. 2011;51(9):1374–1387.
   PubMed Web of Science ®Google Scholar
• Winner P, Linder S, Hershey AD. Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence. Headache. 2015;55:519–528.
   PubMed Web of Science ®Google Scholar
• Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Pract. 2000;54:466–469.
   PubMed Web of Science ®Google Scholar
• Evers S, Rahmann A, Kraemer C, et al. Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology. 2006;67:497–499.
   PubMed Web of Science ®Google Scholar
• Rothner AD, Wasiewki W, Winner P, et al. Zolmitriptan oral tablet in migraine treatment: high placebo response in adolescents. Headache. 2006;46:101–109.
   PubMed Web of Science ®Google Scholar
• Lewis DW, Winner P, Hershey AD, et al. Adolescent migraine steering committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics. 2007;120:390–396.
   PubMed Web of Science ®Google Scholar
• Winner P, Farkas V, Štillová H, et al. Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: results of a randomized, double-blind, multi-center, parallel-group study (TEENZ). Headache. 2016;56(7):1107–1119.
   PubMed Web of Science ®Google Scholar
• Winner P, Lewis D, Visser WH, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache. 2002;42:49–55.
   PubMed Web of Science ®Google Scholar
• Visser WH, Winner P, Strohmaier K, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache. 2004;44:891–899.
   PubMed Web of Science ®Google Scholar
• Ahonen K, Hämäläinen ML, Eerola M, et al. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67:1135–1140.
   PubMed Web of Science ®Google Scholar
• Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia. 2012;32(10):750–765.
   PubMed Web of Science ®Google Scholar
• Charles JA. Almotriptan in the acute treatment of migraine in patients 11–17 years old: an open-label pilot study of efficacy and safety. J Headache Pain. 2006;7:95–97.
   PubMedGoogle Scholar
• Linder SL, Mathew NT, Cady RK, et al. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008;48(9):1326–1336.
   PubMed Web of Science ®Google Scholar
• Winner P, Linder SL, Lipton RB, et al. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache. 2007;47:511–518.
   PubMed Web of Science ®Google Scholar
• Elkind AH, Wade A, Ishkanian G. Pharmacokinetics of frovatriptan in adolescent migraineurs. J Clin Pharmacol. 2004;44(10):1158–1165.
   PubMed Web of Science ®Google Scholar
• Christensen ML, Eades SK, Fuseau E, et al. Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. J Clin Pharmacol. 2001;41(2):170–175.
   PubMed Web of Science ®Google Scholar
• Rothner A, Edwards K, Kerr L, et al. Efficacy and safety of naratriptan tablets in adolescent migraine. J Neurol Sci. 1997;Suppl.1:106,150.
   Google Scholar
• Hämäläinen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997 Jan;48(1):103–107.
   PubMed Web of Science ®Google Scholar
• Lewis DW, Kellstein D, Dahl G, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–786.
   PubMed Web of Science ®Google Scholar
• Brousseau DC, Duffy SJ, Anderson AC. A randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256–262.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Kori SH. Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine. CNS Drugs. 2013;27(5):385–394.
   PubMed Web of Science ®Google Scholar
• Linder SL. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34(10):578–580.
   PubMed Web of Science ®Google Scholar
• Kabbouche MA, Powers SW, Segers A, et al. Inpatient treatment of status migraine with dihydroergotamine in children and adolescents. Headache. 2009;49(1):106–109.
   PubMed Web of Science ®Google Scholar
• Raina M, Chelimsky G, Chelimsky T. Intravenous dihydroergotamine therapy for pediatric abdominal migraines. Clin Pediatr. 2013;52(10):918–921.
   PubMed Web of Science ®Google Scholar
• Hamalainen ML, Hoppu K, Santavuori PR. Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol. 1997;16:114–117.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Fofi L, Aurilia C, et al. Dopaminergic symptoms in migraine. Neurol Sci. 2013;Suppl 1:67–70.
   Google Scholar
• Kelley NE, Tepper DE. Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others. Headache. 2012;52(2):292–306.
   PubMed Web of Science ®Google Scholar
• Kabbouche MA, Vockell AL, LeCates SL, et al. Tolerability and effectiveness of prochlorperazine for intractable migraine in children. Pediatrics. 2001;107(4):E62.
   PubMed Web of Science ®Google Scholar
• Kanis JM, Timm NL. Chlorpromazine for the treatment of migraine in a pediatric emergency department. Headache. 2014 Feb;54(2):335–342.
   PubMed Web of Science ®Google Scholar
• Patniyot IR, Gelfand AA. Acute treatment therapies for pediatric migraine: a qualitative systematic review. Headache. 2016;56:49–70.
   PubMed Web of Science ®Google Scholar
• Richer LP, Laycock K, Millar K, et al. Treatment of children with migraine in emergency departments: national practice variation study. Pediatrics. 2010;126(1):150–155.
   Web of Science ®Google Scholar
• Sheridan DC, Laurie A, Pacheco S, et al. Relative effectiveness of dopamine antagonists for pediatric migraine in the emergency department. Pediatr Emerg Care. 2018;34(3):165–168.
   PubMed Web of Science ®Google Scholar
• Trottier ED, Bailey B, Lucas N, et al. Prochlorperazine in children with migraine: a look at its effectiveness and rate of akathisia. Am J Emerg Med. 2012;30(3):456–463.
   PubMed Web of Science ®Google Scholar
• Reiter PD, Nickisch J, Merritt G. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache. 2005;45(7):899–903.
   PubMed Web of Science ®Google Scholar
• Trottier ED, Bailey B, Dauphin-Pierre S, et al. Clinical outcomes of children treated with intravenous prochlorperazine for migraine in a pediatric emergency department. J Emerg Med. 2010;39(2):166–173.
   PubMed Web of Science ®Google Scholar
• Sheridan DC, Hansen ML, Lin AL, et al. Low-dose propofol for pediatric migraine: a prospective, randomized controlled trial. J Emerg Med. 2018;54(5):600–606.
   PubMed Web of Science ®Google Scholar
• Eapen A, Sivaswamy L, Agarwal R, et al. Management of pediatric migraine in a tertiary care versus community based emergency department: an observational pilot study. Pediatr Neurol. 2014;50:164–170.
   PubMed Web of Science ®Google Scholar
• Sheridan DC, Meckler GD. Inpatient pediatric migraine treatment: does choice of abortive therapy affect length of stay? J Pediatr. 2016;179:211–215.
   PubMed Web of Science ®Google Scholar
• Kabbouche MA. Pediatric inpatient headache therapy: what is available. Headache. 2015;55(10):1426–1429.
   PubMed Web of Science ®Google Scholar
• Hershey AD. Current approaches to the diagnosis and management of pediatric migraine. Lancet Neurol. 2010;9:190–204.
   PubMed Web of Science ®Google Scholar
• Major PW, Grubisa HS, Thie NM. Triptans for treatment of acute pediatric migraine: a systematic literature review. Pediatr Neurol. 2003;29(5):425–429.
   PubMed Web of Science ®Google Scholar
• Johnson HF, Goadsby PJ, Gelfand AA. Predictors of triptan response in pediatric migraine. Pediatr Neurol. 2016;58:37–40.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Fabbrini G, Vanacore N, et al. Sumatriptan in migraine with unilateral cranial autonomic symptoms: an open study. Headache. 2003;43(4):400–403.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Fofi L, Dall’Armi V, et al. Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial. J Headache Pain. 2012;13(5):407–414.
   PubMed Web of Science ®Google Scholar
• Barbanti P, Egeo G. Pharmacological trials in migraine: it’s time to reappraise where the headache is and what the pain is like. Headache. 2015;55(3):439–441.
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Pascual J, Ramadan N, et al. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia. 2012;32(1):6–38.
   PubMed Web of Science ®Google Scholar
• Karabetsos A, Karachalios G, Bourlinou P. Ketoprofen versus paracetamol in the treatment of acute migraine. Headache. 1997;37(1):12–14.
   PubMed Web of Science ®Google Scholar
• Derry S, Rabbie R, Moore RA. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013 Apr 30;(4):CD008783.
   PubMed Web of Science ®Google Scholar
• Anthony M, Lance JW. Indomethacin in migraine. Med J. 1968 Jan;1(2):56–57. Aust.
   Google Scholar
• Hoy SM, Scott LJ. Indomethacin/prochlorperazine/caffeine: a review of its use in the acute treatment of migraine and in the treatment of episodic tension-type headache. CNS Drugs. 2011;25(4):343–358.
   PubMed Web of Science ®Google Scholar
• Vila-Pueyo M. Targeted 5-HT1F therapies for migraine. Neurotherapeutics. 2018;15(2):291–303.
   PubMed Web of Science ®Google Scholar
• Messina R, Goadsby PJ. CGRP – a target for acute migraine: clinical data. Cephalalgia. 2018 Jan 1; 333102418768095. DOI:10.1177/0333102418768095.
   PubMedGoogle Scholar